BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 18209069)

  • 1. Identification of Pax5 target genes in early B cell differentiation.
    Pridans C; Holmes ML; Polli M; Wettenhall JM; Dakic A; Corcoran LM; Smyth GK; Nutt SL
    J Immunol; 2008 Feb; 180(3):1719-28. PubMed ID: 18209069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pax5: the guardian of B cell identity and function.
    Cobaleda C; Schebesta A; Delogu A; Busslinger M
    Nat Immunol; 2007 May; 8(5):463-70. PubMed ID: 17440452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcription factor Pax5 activates the chromatin of key genes involved in B cell signaling, adhesion, migration, and immune function.
    Schebesta A; McManus S; Salvagiotto G; Delogu A; Busslinger GA; Busslinger M
    Immunity; 2007 Jul; 27(1):49-63. PubMed ID: 17658281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional regulation in early B cell development.
    Fuxa M; Skok JA
    Curr Opin Immunol; 2007 Apr; 19(2):129-36. PubMed ID: 17292598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene repression by Pax5 in B cells is essential for blood cell homeostasis and is reversed in plasma cells.
    Delogu A; Schebesta A; Sun Q; Aschenbrenner K; Perlot T; Busslinger M
    Immunity; 2006 Mar; 24(3):269-81. PubMed ID: 16546096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pax5 maintains cellular identity by repressing gene expression throughout B cell differentiation.
    Carotta S; Holmes ML; Pridans C; Nutt SL
    Cell Cycle; 2006 Nov; 5(21):2452-6. PubMed ID: 17102626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The regulation of the B-cell gene expression programme by Pax5.
    Holmes ML; Pridans C; Nutt SL
    Immunol Cell Biol; 2008 Jan; 86(1):47-53. PubMed ID: 17998914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myeloid lineage switch of Pax5 mutant but not wild-type B cell progenitors by C/EBPalpha and GATA factors.
    Heavey B; Charalambous C; Cobaleda C; Busslinger M
    EMBO J; 2003 Aug; 22(15):3887-97. PubMed ID: 12881423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repression of Flt3 by Pax5 is crucial for B-cell lineage commitment.
    Holmes ML; Carotta S; Corcoran LM; Nutt SL
    Genes Dev; 2006 Apr; 20(8):933-8. PubMed ID: 16618805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogenic role of Pax5 in the T-lymphoid lineage upon ectopic expression from the immunoglobulin heavy-chain locus.
    Souabni A; Jochum W; Busslinger M
    Blood; 2007 Jan; 109(1):281-9. PubMed ID: 16968900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of Notch1 function by in vitro T cell differentiation of Pax5 mutant lymphoid progenitors.
    Höflinger S; Kesavan K; Fuxa M; Hutter C; Heavey B; Radtke F; Busslinger M
    J Immunol; 2004 Sep; 173(6):3935-44. PubMed ID: 15356142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pax5 promotes B lymphopoiesis and blocks T cell development by repressing Notch1.
    Souabni A; Cobaleda C; Schebesta M; Busslinger M
    Immunity; 2002 Dec; 17(6):781-93. PubMed ID: 12479824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reporter gene insertions reveal a strictly B lymphoid-specific expression pattern of Pax5 in support of its B cell identity function.
    Fuxa M; Busslinger M
    J Immunol; 2007 Jun; 178(12):8222-8. PubMed ID: 17600970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcription factor EBF restricts alternative lineage options and promotes B cell fate commitment independently of Pax5.
    Pongubala JM; Northrup DL; Lancki DW; Medina KL; Treiber T; Bertolino E; Thomas M; Grosschedl R; Allman D; Singh H
    Nat Immunol; 2008 Feb; 9(2):203-15. PubMed ID: 18176567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oscillation between B-lymphoid and myeloid lineages in Myc-induced hematopoietic tumors following spontaneous silencing/reactivation of the EBF/Pax5 pathway.
    Yu D; Allman D; Goldschmidt MH; Atchison ML; Monroe JG; Thomas-Tikhonenko A
    Blood; 2003 Mar; 101(5):1950-5. PubMed ID: 12406913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pax5: a master regulator of B cell development and leukemogenesis.
    Medvedovic J; Ebert A; Tagoh H; Busslinger M
    Adv Immunol; 2011; 111():179-206. PubMed ID: 21970955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pax5--a critical inhibitor of plasma cell fate.
    Nera KP; Lassila O
    Scand J Immunol; 2006 Sep; 64(3):190-9. PubMed ID: 16918686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Essential functions of Pax5 (BSAP) in pro-B cell development: difference between fetal and adult B lymphopoiesis and reduced V-to-DJ recombination at the IgH locus.
    Nutt SL; Urbánek P; Rolink A; Busslinger M
    Genes Dev; 1997 Feb; 11(4):476-91. PubMed ID: 9042861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mechanism of repression of the myeloid-specific c-fms gene by Pax5 during B lineage restriction.
    Tagoh H; Ingram R; Wilson N; Salvagiotto G; Warren AJ; Clarke D; Busslinger M; Bonifer C
    EMBO J; 2006 Mar; 25(5):1070-80. PubMed ID: 16482219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Losing B cell identity.
    Carotta S; Nutt SL
    Bioessays; 2008 Mar; 30(3):203-7. PubMed ID: 18293359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.